Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Additional Information (Details)

v3.22.2
Financial Instruments - Additional Information (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Dec. 08, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Marketable equity securities $ 23,864    
Gross unrealized gains 3,859    
Contingent consideration, liability (up to) 2,824    
Investments in privately held entities $ 13,300 $ 5,000  
Company X | Contingent Consideration - Company X      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration, liability (up to)     $ 3,000